Francis R B
Thromb Res. 1986 Feb 1;41(3):337-44. doi: 10.1016/0049-3848(86)90244-6.
A simplified assay for protein C activity in plasma is described which uses the ability of rabbit lung thrombomodulin to inhibit the procoagulant activity of thrombin while stimulating protein C activation. Barium eluates of plasma are activated for one hour at 37 degrees C by a mixture of human thrombin and rabbit lung thrombomodulin at concentrations which neutralize each other's effect on the kaolin-cephalin activated partial thromboplastin time (PTT). Protein C anticoagulant activity in the activated eluates is then measured directly in the PTT. The method is independent of protein S levels in the test samples, and is suitable for warfarinized and heparinized plasma. Protein C levels obtained with this method correlate closely with functional levels of vitamin K-dependent procoagulants as measured by the prothrombin and proconvertin time (P&P) in normal subjects and in patients receiving warfarin, indicating specificity for gamma-carboxylated protein C. The method has the potential to detect molecular variants defective in any of the interactions required for generation of anticoagulant activity in vivo.
本文描述了一种用于检测血浆中蛋白C活性的简化检测方法,该方法利用兔肺血栓调节蛋白抑制凝血酶促凝活性同时刺激蛋白C活化的能力。血浆钡洗脱液在37℃下由人凝血酶和兔肺血栓调节蛋白的混合物激活1小时,这两种物质的浓度相互抵消对方对高岭土 - 脑磷脂活化部分凝血活酶时间(PTT)的影响。然后直接在PTT中测量活化洗脱液中的蛋白C抗凝活性。该方法与测试样品中的蛋白S水平无关,适用于服用华法林和肝素化的血浆。用该方法获得的蛋白C水平与正常受试者和接受华法林治疗的患者中通过凝血酶原和前转变素时间(P&P)测量的维生素K依赖性促凝剂的功能水平密切相关,表明对γ-羧化蛋白C具有特异性。该方法有可能检测体内抗凝活性产生所需的任何相互作用中存在缺陷的分子变体。